loadpatents
Patent applications and USPTO patent grants for Selvaraj; Anand.The latest application filed is for "combination therapies for the treatment of hepatocellular carcinoma".
Patent | Date |
---|---|
Drug combinations for reducing cell viability and/or cell proliferation Grant 11,357,769 - Selvaraj , et al. June 14, 2 | 2022-06-14 |
Pyrimidine FGFR4 inhibitors Grant 10,912,774 - Reynolds , et al. February 9, 2 | 2021-02-09 |
Combination Therapies for the Treatment of Hepatocellular Carcinoma App 20200360371 - Selvaraj; Anand ;   et al. | 2020-11-19 |
Pyrimidine Fgfr4 Inhibitors App 20200206222 - REYNOLDS; Dominic ;   et al. | 2020-07-02 |
Pyrimidine FGFR4 inhibitors Grant 10,537,571 - Reynolds , et al. Ja | 2020-01-21 |
Combination Therapies For The Treatment Of Hepatocellular Carcinoma App 20190175598 - Selvaraj; Anand ;   et al. | 2019-06-13 |
Drug Combinations For Reducing Cell Viability And/or Cell Proliferation App 20190117640 - Selvaraj; Anand ;   et al. | 2019-04-25 |
Pyrimidine Fgfr4 Inhibitors App 20170360785 - REYNOLDS; Dominic ;   et al. | 2017-12-21 |
Pyrimidine FGFR4 inhibitors Grant 9,730,931 - Reynolds , et al. August 15, 2 | 2017-08-15 |
Pyrimidine Fgfr4 Inhibitors App 20170007601 - REYNOLDS; Dominic ;   et al. | 2017-01-12 |
Pyrimidine FGFR4 inhibitors Grant 9,434,697 - Reynolds , et al. September 6, 2 | 2016-09-06 |
Pyrimidine Fgfr4 Inhibitors App 20160130237 - Reynolds; Dominic ;   et al. | 2016-05-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.